Early clinical trials show promising weight loss potential in non-diabetic patients
How Novo Nordisk revenue growth stacks up against rivals Semaglutide sales skyrocket In 2022, Ozempic sales surged by 77% in DKK and 61% at constant exchange rates, reaching DKK 59,750 million (USD 8.4 billion)
Animal studies using galectin-3 protein inhibitors have demonstrated a decrease in fibrosis which has subsequently been replicated in phase I human studies.78 An initial phase IIa trial of GR-MD-02 given over 16 weeks assessed change in fibrosis by MRI in 30 patients with biopsy proven NASH and stage 3 fibrosis.79 Although this study did not achieve its primary endpoint, this agent is undergoing subsequent evaluation in a longer term (one year), randomised, placebo-controlled, phase IIb trial in patients with compensated NASH cirrhosis and portal hypertension (HVPG 6 mmHg)
this is just people's weight, you know, before they started and then, you know, once they started doing every other week," Biermann said
R., and Skibicka, K